Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Scientists have identified a novel strategy to disrupt key cancer-driving proteins in neuroblastoma, a high-risk childhood cancer, by targeting the MYCN oncoprotein’s stability through targeted protein degradation, offering potential for ... Read More
Continuous Coverage
Asian equity markets advanced cautiously on Monday morning as renewed optimism over potential Iran-US nuclear talks eased geopolitical…
Motorola is betting big on a nostalgic revival with its 2026 Razr foldable series, teasing premium materials and…
Usain Bolt warned teenage sprint sensation Gout Gout that his transition to senior athletics in 2026 will be…
A protein known for triggering cell death has been found to silently accelerate aging in blood stem cells…
Sweet James Accident Attorneys, a California-based personal injury law firm, has expanded its market share in the state’s…
India’s ongoing delimitation debate, reignited by political shifts in early 2026, has quietly reshaped the nation’s internal power…
Global Affairs
On April 20, 2026, Russian forces launched a sudden amphibious incursion into Crimea’s northern coast, deploying the Gurza-M…
Markets And Money
In the minutes before major Donald Trump announcements on April 19, 2026, traders executed an unusually high volume…
Digital Culture
Samsung’s Galaxy S27 Ultra is poised to receive a silicon-carbon anode battery upgrade, a development nearly confirmed by…
Science And Wellbeing
Health officials in Northern California are urging vaccinations after confirming a more virulent strain of the mpox virus,…
Screen And Sound
In an era where algorithm-driven playlists dominate listening habits, the enduring power of a song known by heart—every…
Fixtures And Form
Norwegian track and field coach Paul Solberg, renowned for guiding hammer throwers Eivind Henriksen and Thomas Mardal to…
